CALM-AF-AI: Counteracting Age-related Loss of Muscle With AAV-Follistatin Combined With Angiogenesis-Inducing VEGF Plasmid Gene Therapy

NCT07443826 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Age-related Muscle Decline

Interventions

GENETIC: AAV9-Follistatin gene therapy
GENETIC: VEGF Plasmid

Sponsor

Unlimited Biotechnology LLC

Collaborators

[object Object]